Pr Caroline Robert, MD, PhD, is head of the Dermatology Unit in Gustave Roussy Cancer Center, Villejuif-Paris, France. Pr Robert earned her medical degree at the Cochin Port-Royal School of Medicine, Paris, in 1990, after which she was made a faculty member of the graduate school of biological sciences and received her French Board Certification in dermatology in 1992. On gaining her certification, Pr Robert was appointed assistant professor in dermatology at the St-Louis Hospital, Paris. She completed a research fellowship at Harvard University in Boston, Massachusetts, United States, and a PhD in cancer immunology and immunotherapy. In 2000, Pr Robert returned to Europe as medical director for Johnson & Johnson Consumer Europe. In 2001, she took a position at Gustave-Roussy as assistant in dermatology, before becoming head of the Dermatology Unit in 2005. Since 2010, she aslo heads a research laboratory with Dr Stephan Vagner. Her research focuses on the identification of predictive biomarkers of efficacy/tolerance of new drugs in melanoma. She is president of the EORTC Melanoma group since September 2014. She is also a board member of the European Association of Onco-Dermatology (EADO), and a member of the European Association of Dermato-Venereology (EADV), the French society of Dermatology and Venereology, the American Association for Cancer Research (AACR) and the American Society of Clinical Oncology (ASCO)
Pr Robert is a scientist of international renown in the clinical and translational research of melanoma and the cutaneous side-effects of new targeted chemotherapies. She has authored more than 130 articles in peer-reviewed scientific journals, including a number of publications on new treatments for metastatic melanoma, and has been involved in numerous international clinical trials.